ערך בספרים למניה: Ginkgo Bioworks Corp. (DNA)

This price chart for Ginkgo Bioworks Holdings (DNA) represents a cell programming business where the yield is 6.87. The platform's success relies on funding from the agricultural sector and biopharmaceuticals, as well as growth in royalties. However, Ginkgo Bioworks Holdings (DNA) faces colossal costs and expansion difficulties. High spending coupled with a sluggish influx of contracts puts financial stability at risk.

To assess the issuer's financial stability, it is essential to analyze its intrinsic value. This indicator is determined as the ratio of equity to the number of shares outstanding. For Ginkgo Bioworks (DNA), which is burning capital to develop its platform, this calculation is critical. The trend in net asset value per share reflects the risk of dilution during new issuances. This chart allows for the identification of the actual degradation of the asset base.